MELANOCORTIN RECEPTOR AGONIST
A melanocortin receptor agonist studied for its effects on central nervous system pathways related to arousal and desire.
For research and laboratory use only.
Research Profile
PT-141 (Bremelanotide) is explored for its unique mechanism of action through melanocortin receptors in the CNS rather than vascular pathways.
Studied for activation of MC3R and MC4R melanocortin receptors in the CNS.
Explored for central nervous system-mediated effects rather than peripheral vascular action.
Investigated for its role in neuroendocrine signaling and behavioral pathways.
Derived from alpha-melanocyte-stimulating hormone research.
Size Options
Choose the size that fits your research protocol. All sizes undergo the same rigorous third-party testing.
Standard dosage for melanocortin research protocols.
$0.00 Select — 10 mgQuality Assurance
PT-141 undergoes independent third-party laboratory analysis before distribution. Certificates of Analysis are available on request for every lot.
